My Cart

Human ADORA2A Full Length Protein (VLP)

Customer Reviews
Cat. No. / Size
Price
Qty
ADA-H52P4-20ug
$620.00
ADA-H52P4-100ug
$1235.00
ADA-H52P4-500ug
$4305.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Application

    1. Immunization
    2. Cell based assay (FACS or functional assay)
    3. Screening (ELISA)
  • Synonyms

    ADORA2A, adenosine A2a receptor, A2aR, ADORA2, RDC8

  • Source

    Human ADORA2A Full Length Protein-VLP (ADA-H52P4) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Ser 412 (Accession # P29274-1).

    Predicted N-terminus: Met 1

  • Molecular Characterization

    *The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.

    2. Synthesis Process

      Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >95% as determined by SEC-HPLC.

  • Formulation

    The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

    Supplied as 0.2 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 12 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SEC-HPLC

    ADORA2A SEC-HPLC

    The purity of Human ADORA2A Full Length Protein-VLP (Cat. No. ADA-H52P4) was greater than 95% as determined by SEC-HPLC.

  • Bioactivity-ELISA

     ADORA2A ELISA

    Immobilized Human ADORA2A Full Length Protein-VLP (Cat. No. ADA-H52P4) at 5 μg/mL (100 μL/well) can bind Monoclonal Anti-Human ADORA2A antibody, Human IgG1 with a linear range of 0.3-5 ng/mL (QC tested).

    Protocol
  • Identity-DLS

     ADORA2A DLS

    The mean peak Radius of VLP is 55-70 nm with more than 95% intensity as determined by dynamic light scattering (DLS).

Customer Reviews
Writing Reviews

Background

The Adenosine A2A Receptor, a GPCR highly expressed on immune cells within the hypoxic tumor microenvironment. Adenosine signaling via A2AR potently suppresses T cell activation and effector function. Antagonists of ADORA2A are in clinical development to reverse adenosine-mediated immunosuppression and enhance anti-tumor immunity.

Recent Advances

 
Drug Development Progress
  • English Name:

    Adenosine A2a receptor

  • Category:

  • Approved Drugs:

    53 Details

  • Drugs in Clinical Trials:

    25 Details

  • Highest Development Stage:

    Approved

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background